Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
messenger RNA
Biotech
Moderna slashes R&D spending, drops 5 programs
The decision to shrink the R&D budget by 20% follows commercial setbacks that drove the biotech to take a “more selective and paced approach” to R&D.
Nick Paul Taylor
Sep 12, 2024 8:10am
CureVac gains $430M GSK vaccine contract, loses 30% of staff
Jul 3, 2024 5:00am
Pfizer's mRNA flu vaccine hits primary goals in phase 3 trial
Oct 31, 2023 7:53am
Pfizer, BioNTech prep flu-COVID mRNA combo vaccine for phase 3
Oct 26, 2023 9:32am
Sanofi, BioNTech scrap mRNA cancer drug based on early data
Jul 28, 2023 6:53am
Moderna’s protein replacement therapy passes early clinical test
May 19, 2023 10:10am
